Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players—excitatory neurons—when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
Learn more: Cell Therapy Could Improve Brain Function for Alzheimer’s disease
The Latest on: Alzheimer’s Disease
[google_news title=”” keyword=”Alzheimers Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s Disease
- From understanding Parkinson’s Disease to the increased rate of cancer cases, here are this week’s talkbackson April 27, 2024 at 7:22 pm
WGAL News 8 talks to professionals to give a better understanding of important events impacting the Susquehanna Valley.
- Study says these three diets reduce Alzheimer's diseaseon April 26, 2024 at 1:48 pm
New research showed people's diet and other activities that challenge the brain may help fight off Alzheimer's disease.
- Alzheimer's All-Star Basketball Classic's founder, Gordon Thomas, inspired by dad's battle with diseaseon April 26, 2024 at 11:50 am
Celeste Taylor, Lester Quinones and Diego Maldonado are just a few of the talented players who have participated in the competitions.
- Study finds RNA modification is responsible for disruption of mitochondrial protein synthesis in Alzheimer's diseaseon April 25, 2024 at 9:29 am
A team of researchers at Johannes Gutenberg University Mainz (JGU) has identified a mechanism that causes mitochondrial dysfunction in Alzheimer's patients resulting in a reduction of the supply of ...
- The number of people with Alzheimer’s disease in their 40s or 50s could be underestimatedon April 24, 2024 at 8:33 am
Could you develop this disease at such an early age? Your family history could be telling, medical professionals say.
- Alzheimer's Newson April 23, 2024 at 5:00 pm
RNA Modification Is Responsible for the Disruption of Mitochondrial Protein Synthesis in Alzheimer's Disease Apr. 25, 2024 — A team of researchers has identified a mechanism that causes ...
- Alzheimer’s Disease Neurons Reenter Cell Cycle, Become Senescenton April 23, 2024 at 3:56 pm
Senescent cells displayed more proinflammatory, metabolically deregulated, and pathology-associated signatures ...
- Keto diet may help lower cholesterol, toxic proteins in Alzheimer’s diseaseon April 23, 2024 at 10:31 am
New research in rat models of Alzheimer's disease suggests that a ketogenic diet may help lower blood lipids and tau protein levels, improving Alzheimer's-like symptoms.
- Gut Microbiome Linked to Alzheimer's Disease, Scientists Sayon April 23, 2024 at 3:23 am
The findings could lead to the development of new therapeutic interventions or drugs to prevent Alzheimer's disease.
via Bing News